RLMD

Relmada Therapeutics, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Kelly Paul EdwardDirector
$65k25k shares
BuySep 9, 2024
$2.59
--
Shenouda MagedChief Financial Officer
$21k8.2k shares
BuySep 9, 2024
$2.55
--
Shenouda MagedChief Financial Officer
$58k21.1k shares
BuySep 10, 2024
$2.73
--
Shenouda MagedChief Financial Officer
$71k24.1k shares
BuySep 11, 2024
$2.95
--
Casamento Charles JDirector
$33k13k shares
BuySep 9, 2024
$2.56
--
Traversa SergioDirector, Officer: Chief Executive Officer
$151k55.6k shares
BuySep 9, 2024
$2.71
--

News

benzinga.comRelmada's Cancer Drug Candidate Sparks Fresh Bullish Callbenzinga.comJun 18globenewswire.comRelmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Programglobenewswire.comJun 11globenewswire.comRelmada Therapeutics to Present at the Jefferies Global Healthcare Conferenceglobenewswire.comMay 28marketbeat.comRelmada Therapeutics Q1 Earnings Call Highlightsmarketbeat.comMay 12seekingalpha.comRelmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call Transcriptseekingalpha.comMay 12
RLMD smart money exposure | 交易笔记